Deals Of The Week: Bristol And Others May Be Eyeing A Bid For Shire
Executive Summary
Shire girds for anticipated renewal of takeover interest by Bristol-Myers, while Perrigo begins getting acclimated in its new home. Plus news on a pair of antibody partnerships by Adimab and a muscular dystrophy research collaboration between Evotec and the Jain Foundation.